⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 28, 2020Antimicrobial Agents and ChemotherapyOpen Access

Pharmacodynamic Evaluation of MRX-8, a Novel Polymyxin, in the Neutropenic Mouse Thigh and Lung Infection Models against Gram-Negative Pathogens

View Full Paper

Ask AI

Bookmark

Share

Abstract

activity against many different clinically relevant species in both the mouse thigh and lung models.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lepak et al. (2020) studied this question.

synapsesocial.com/papers/6a010faf831589f3542dfdef https://doi.org/10.1128/aac.01517-20

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection modelsOriginal Research · 2010 · 187 citations
2State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenOriginal Research · 1998 · 2,910 citations
3New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against<i>Pseudomonas aeruginosa</i>and<i>Acinetobacter baumannii</i>in mouse thigh and lung infection models: smaller response in lung infectionOriginal Research · 2015 · 209 citations
4Pharmacodynamics of Polymyxin B against <i>Pseudomonas aeruginosa</i>Original Research · 2005 · 204 citations
5International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)Clinical Guideline · 2019 · 957 citations